vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and Western New England Bancorp, Inc. (WNEB). Click either name above to swap in a different company.

Western New England Bancorp, Inc. is the larger business by last-quarter revenue ($22.0M vs $16.7M, roughly 1.3× ASP Isotopes Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs 18.8%). Western New England Bancorp, Inc. produced more free cash flow last quarter ($17.1M vs $-47.4M).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

The Bank of New England Corporation refers to a current online real estate bank based in New Hampshire and former regional banking institution based in Boston, Massachusetts, which was seized by the Federal Deposit Insurance Corporation (FDIC) in 1991 as a result of heavy losses in its loan portfolio and was placed into Chapter 7 liquidation. At the time, it was the 33rd largest bank in the United States, and its federal seizure bailout was the second-largest on record. At its peak, it had be...

ASPI vs WNEB — Head-to-Head

Bigger by revenue
WNEB
WNEB
1.3× larger
WNEB
$22.0M
$16.7M
ASPI
Growing faster (revenue YoY)
ASPI
ASPI
+1276.9% gap
ASPI
1295.7%
18.8%
WNEB
More free cash flow
WNEB
WNEB
$64.6M more FCF
WNEB
$17.1M
$-47.4M
ASPI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ASPI
ASPI
WNEB
WNEB
Revenue
$16.7M
$22.0M
Net Profit
$5.2M
Gross Margin
12.5%
Operating Margin
30.1%
Net Margin
23.7%
Revenue YoY
1295.7%
18.8%
Net Profit YoY
-586.8%
58.4%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
WNEB
WNEB
Q4 25
$16.7M
$22.0M
Q3 25
$4.9M
$21.3M
Q2 25
$21.1M
Q1 25
$18.3M
Q4 24
$18.5M
Q3 24
$17.9M
Q2 24
$18.3M
Q1 24
$18.0M
Net Profit
ASPI
ASPI
WNEB
WNEB
Q4 25
$5.2M
Q3 25
$-12.9M
$3.2M
Q2 25
$4.6M
Q1 25
$2.3M
Q4 24
$3.3M
Q3 24
$1.9M
Q2 24
$3.5M
Q1 24
$3.0M
Gross Margin
ASPI
ASPI
WNEB
WNEB
Q4 25
12.5%
Q3 25
8.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ASPI
ASPI
WNEB
WNEB
Q4 25
30.1%
Q3 25
-306.1%
19.7%
Q2 25
28.6%
Q1 25
16.2%
Q4 24
23.5%
Q3 24
14.1%
Q2 24
23.4%
Q1 24
21.0%
Net Margin
ASPI
ASPI
WNEB
WNEB
Q4 25
23.7%
Q3 25
-263.7%
14.9%
Q2 25
21.8%
Q1 25
12.6%
Q4 24
17.7%
Q3 24
10.7%
Q2 24
19.2%
Q1 24
16.4%
EPS (diluted)
ASPI
ASPI
WNEB
WNEB
Q4 25
$0.25
Q3 25
$-0.15
$0.16
Q2 25
$0.23
Q1 25
$0.11
Q4 24
$0.16
Q3 24
$0.09
Q2 24
$0.17
Q1 24
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
WNEB
WNEB
Cash + ST InvestmentsLiquidity on hand
$333.3M
Total DebtLower is stronger
$14.4M
Stockholders' EquityBook value
$204.2M
$247.6M
Total Assets
$498.0M
$2.7B
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
WNEB
WNEB
Q4 25
$333.3M
Q3 25
$113.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
ASPI
ASPI
WNEB
WNEB
Q4 25
$14.4M
Q3 25
$13.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPI
ASPI
WNEB
WNEB
Q4 25
$204.2M
$247.6M
Q3 25
$74.1M
$243.6M
Q2 25
$239.4M
Q1 25
$237.7M
Q4 24
$235.9M
Q3 24
$240.7M
Q2 24
$236.5M
Q1 24
$235.8M
Total Assets
ASPI
ASPI
WNEB
WNEB
Q4 25
$498.0M
$2.7B
Q3 25
$225.9M
$2.7B
Q2 25
$2.7B
Q1 25
$2.7B
Q4 24
$2.7B
Q3 24
$2.6B
Q2 24
$2.6B
Q1 24
$2.6B
Debt / Equity
ASPI
ASPI
WNEB
WNEB
Q4 25
0.07×
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
WNEB
WNEB
Operating Cash FlowLast quarter
$-37.8M
$18.2M
Free Cash FlowOCF − Capex
$-47.4M
$17.1M
FCF MarginFCF / Revenue
-284.7%
77.9%
Capex IntensityCapex / Revenue
57.9%
4.9%
Cash ConversionOCF / Net Profit
3.50×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
WNEB
WNEB
Q4 25
$-37.8M
$18.2M
Q3 25
$-8.9M
$5.6M
Q2 25
$6.8M
Q1 25
$-1.2M
Q4 24
$12.2M
Q3 24
$3.0M
Q2 24
$2.0M
Q1 24
$1.2M
Free Cash Flow
ASPI
ASPI
WNEB
WNEB
Q4 25
$-47.4M
$17.1M
Q3 25
$-12.0M
Q2 25
Q1 25
Q4 24
$11.0M
Q3 24
Q2 24
Q1 24
FCF Margin
ASPI
ASPI
WNEB
WNEB
Q4 25
-284.7%
77.9%
Q3 25
-245.5%
Q2 25
Q1 25
Q4 24
59.2%
Q3 24
Q2 24
Q1 24
Capex Intensity
ASPI
ASPI
WNEB
WNEB
Q4 25
57.9%
4.9%
Q3 25
64.4%
Q2 25
Q1 25
Q4 24
6.5%
Q3 24
Q2 24
Q1 24
Cash Conversion
ASPI
ASPI
WNEB
WNEB
Q4 25
3.50×
Q3 25
1.76×
Q2 25
1.49×
Q1 25
-0.54×
Q4 24
3.70×
Q3 24
1.57×
Q2 24
0.56×
Q1 24
0.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons